Accelerate Diagnostics Inc
0.9342 - 1.08
0.502 - 8.05
Join Discuss about AXDX with like-minded investors
Next Dividend Date
Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The FDA cleared system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1-2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier.
CEO: John Phillips
HQ: 3950 S Country Club Rd Ste 470 Bldg 3-307 Tucson, 85714-2240 Arizona